Riskpilot← Back to searchSign inGet full accessNaprapat Mats Widehammar AB
ABIn liquidationOrg 5591089791Other human health activities · NACE 8690Est. 20172 employees
Revenue 2021
SEK 0
EBITDA margin
—
+71% vs 2020
Equity ratio
98.1%
Financial strength
Net profit 2021
SEK -2K
+71% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -2K | +71% |
| Net profit | SEK -2K | +71% |
| Total assets | SEK 54K | -18% |
| Equity | SEK 53K | -4% |
| Employees | 2 | — |
Legal name
Naprapat Mats Widehammar AB
Org number
5591089791
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
18 april 2017
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Naprapatbehandlingar
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 472 | 1 409 | 872 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 90 | 177 | 160 | −7 | −2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 90 | 177 | 160 | −7 | −2 |
| Net financials | — | — | — | — | — |
| Profit before tax | 90 | 177 | 160 | −7 | −2 |
| Tax | −20 | −40 | −35 | −0 | −0 |
| Net profit | 70 | 137 | 125 | −7 | −2 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 199 | 372 | 213 | 66 | 54 |
| Equity | 120 | 207 | 182 | 55 | 53 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 79 | 165 | 31 | 10 | 1 |
| Total debt | 79 | 165 | 31 | 10 | 1 |
EBITDA margin
-200000.0%
This company
15.8%
Market median
-1265923% vs market
20172021
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
20172021
Return on equity
-3.8%
This company
18.4%
Market median
-121% vs market
20172021
Net profit margin
-200000.0%
This company
8.1%
Market median
-2469236% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-04-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MI Liquidator | Liquidator | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naprapat Mats Widehammar AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Matts Ingemar Zetterström | Liquidator | 0 companies |
| Mats Gustav Armandt | Chairman | 0 companies |
| Maja Christina Armandt | Board of Directors | 0 companies |
| Lena Ingegerd Frisk | Deputy Board Member | 0 companies |